Projects per year
Abstract
Membranous nephropathy leads to end-stage renal disease in more than 20% of patients. Although immunosuppressive therapy benefits some patients, trial evidence for the subset of patients with declining renal function is not available. We aimed to assess whether immunosuppression preserves renal function in patients with idiopathic membranous nephropathy with declining renal function.
Original language | English |
---|---|
Pages (from-to) | 744-751 |
Number of pages | 8 |
Journal | Lancet |
Volume | 381 |
Issue number | 9868 |
DOIs | |
Publication status | Published - 2 Mar 2013 |
Bibliographical note
Copyright © 2013 Elsevier Ltd. All rights reserved.Keywords
- Drug Administration Schedule
- Cyclosporine
- Chlorambucil
- Humans
- Glomerulonephritis, Membranous
- Immunosuppressive Agents
- Great Britain
- Drug Therapy, Combination
- Glomerular Filtration Rate
- Prednisolone
- Kidney
- Middle Aged
- Survival Analysis
Fingerprint
Dive into the research topics of 'Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial'. Together they form a unique fingerprint.Projects
- 1 Finished
-
IMMUNOSUPPRESSION FOR PROGRESSIVE MEMBRANOUS NEPHROPATHY
Mathieson, P. W. (Principal Investigator)
1/04/99 → 1/04/09
Project: Research